Zobrazeno 1 - 10
of 163
pro vyhledávání: '"A. M. H. Brodie"'
Publikováno v:
ChemInform. 28
Autor:
V. C. O. Njar, A. M. H. Brodie
Publikováno v:
ChemInform. 30
Publikováno v:
Cancer research. 68(12)
Using the intratumoral aromatase xenograft model, we have observed that despite long-lasting growth inhibition, tumors eventually begin to grow during continued letrozole treatment. In cells isolated from these long-term letrozole-treated tumors (LTL
Publikováno v:
Biopharmaceuticsdrug disposition. 27(7)
The effects of single doses of tamoxifen (TAM; 0.5-5 mg/kg, i.v.) and chronic pretreatment with TAM (0.1-5.0 mg/kg/day, i.p. for 7 consecutive days) on letrozole (0.5 mg/kg, i.v.) pharmacokinetics were evaluated in female Sprague-Dawley rats. The pla
Autor:
James N. Ingle, Luciana Macedo, Danijela Jelovac, Brian J. Long, Venkatesh D. Handratta, Angela M. H. Brodie, Olga Goloubeva
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(21)
Purpose: To optimize treatment strategies for postmenopausal breast cancer patients, we investigated the efficacy of the steroidal aromatase inhibitor exemestane alone or in combination with the antiestrogen tamoxifen in a xenograft model of postmeno
Autor:
Angela M. H. Brodie
Publikováno v:
Breast Cancer ISBN: 9780429221712
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e91e252b95704c3750ef334d43c7d4ed
https://doi.org/10.3109/9780203909249-11
https://doi.org/10.3109/9780203909249-11
Autor:
Angela M. H. Brodie
Publikováno v:
Hormones and Cancer ISBN: 9781461287155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08b9b6bfbfcaa5efd335e9999986b807
https://doi.org/10.1007/978-1-4612-4266-6_12
https://doi.org/10.1007/978-1-4612-4266-6_12
Autor:
Serdar E. Bulun, S. E. Inkster, I. M. Rosenthal, W. P. Zeller, Evan R. Simpson, A. M. Digeorge, Michael W. Kilgore, S. D. Frasier, A. M. H. Brodie
Publikováno v:
The Journal of clinical endocrinology and metabolism. 77(6)
We have previously demonstrated that the tissue-specific regulation of human aromatase cytochrome P450 (P450arom) gene expression is, in part, the consequence of the use of tissue-specific promoters. Promoter I.1 (PI.1) and PI.2-specific transcripts
Autor:
Rabia A. Gilani, Vincent C. O. Njar, Olga Goloubeva, Angela M. H. Brodie, Lalji K. Gediya, Gauri Sabnis, Luciana Macedo
Publikováno v:
Cancer Research. 69:6128
Abstract #6128 It is well established that approximately 75% of human breast cancers are ER+ and therefore treated with endocrine therapy. In a past few decades endocrine therapy has made significant advancements. However, the application of these ag
Publikováno v:
Acta Crystallographica Section B Structural Crystallography and Crystal Chemistry. 36:201-203
C19H2603, P21212j, a = 18.540 (1), b = 24.348 (4), c = 7.3237 (6) A, V 3306.1 A 3, M r 302.41, Z = 8, D c = 1.22 Mg m-a; 3843 observations, 3114 > 2o¥. 4-Hydroxy-4-androstene-3,17-dione (4OH-A) is an effective inhibitor of estrogen synthetase and ha